PMID- 16542723
OWN - NLM
STAT- MEDLINE
DCOM- 20070928
LR  - 20151119
IS  - 0145-2126 (Print)
IS  - 0145-2126 (Linking)
VI  - 30
IP  - 12
DP  - 2006 Dec
TI  - Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic 
      lymphocytic leukemia.
PG  - 1589-90
AB  - Autoimmune phenomena are reported to occur frequently in B-cell chronic leukemia 
      (B-CLL). Fludarabine, one of the most effective chemotherapeutic agents for CLL, 
      may increase the risk of these phenomena and may be life-threatening. Here we 
      present a case of an 80-year-old man with B-CLL who developed autoimmune 
      hemolytic anemia (AIHA), associated with one cycle of fludarabine treatment, and 
      who was successfully treated with rituximab and prednisolone.
FAU - Nishida, Hiroko
AU  - Nishida H
FAU - Murase, Tadashi
AU  - Murase T
FAU - Ueno, Hironori
AU  - Ueno H
FAU - Park, Jae Wong
AU  - Park JW
FAU - Yano, Takahiro
AU  - Yano T
FAU - Ikeda, Yasuo
AU  - Ikeda Y
LA  - eng
PT  - Case Reports
PT  - Letter
DEP - 20060320
PL  - England
TA  - Leuk Res
JT  - Leukemia research
JID - 7706787
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Monoclonal, Murine-Derived)
RN  - 0 (Antineoplastic Agents)
RN  - 4F4X42SYQ6 (Rituximab)
RN  - 9PHQ9Y1OLM (Prednisolone)
RN  - FA2DM6879K (Vidarabine)
RN  - P2K93U8740 (fludarabine)
SB  - IM
CIN - Leuk Res. 2007 Feb;31(2):267; author reply 268-9. PMID: 16716397
MH  - Aged, 80 and over
MH  - Anemia, Hemolytic, Autoimmune/*complications/diagnosis/drug therapy
MH  - Antibodies, Monoclonal/administration & dosage
MH  - Antibodies, Monoclonal, Murine-Derived
MH  - Antineoplastic Agents/administration & dosage/*adverse effects
MH  - Disease Progression
MH  - Humans
MH  - Infusions, Intravenous
MH  - Leukemia, Lymphocytic, Chronic, B-Cell/*complications/diagnosis/drug therapy
MH  - Male
MH  - Prednisolone/administration & dosage
MH  - Remission Induction
MH  - Risk Factors
MH  - Rituximab
MH  - Treatment Outcome
MH  - Vidarabine/administration & dosage/adverse effects/*analogs & derivatives
EDAT- 2006/03/18 09:00
MHDA- 2007/09/29 09:00
CRDT- 2006/03/18 09:00
PHST- 2006/02/07 00:00 [received]
PHST- 2006/02/07 00:00 [revised]
PHST- 2006/02/07 00:00 [accepted]
PHST- 2006/03/18 09:00 [pubmed]
PHST- 2007/09/29 09:00 [medline]
PHST- 2006/03/18 09:00 [entrez]
AID - S0145-2126(06)00069-5 [pii]
AID - 10.1016/j.leukres.2006.02.011 [doi]
PST - ppublish
SO  - Leuk Res. 2006 Dec;30(12):1589-90. doi: 10.1016/j.leukres.2006.02.011. Epub 2006 
      Mar 20.